In addition, in the OV cohort, TRPM2 was also associated with several chemokines and chemokine receptors that have been shown to promote ovarian cancer progression and metastasis, such as CXCL11-CXCR3 and CXCL12-CXCR4 chemokine axes [36,37]. Here, CXCL12 is linked to ovarian carcinoma.